Example: Heart Attack

Clinical Trials on Retroperitoneal Fibrosis

Total 12 results

    • NCT04047576
      Recruiting
      Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis
      Conditions: Retroperitoneal Fibrosis
    • NCT04762810
      Not yet recruiting
      A Prospective Study of Cyclophosphamide Treatment for Idiopathic Retroperitoneal Fibrosis
      Conditions: Idiopathic Retroperitoneal Fibrosis
    • NCT04762784
      Not yet recruiting
      A Prospective Study of Tocilizumab in the Treatment of Idiopathic Retroperitoneal Fibrosis
      Conditions: Idiopathic Retroperitoneal Fibrosis
    • NCT00440349
      Unknown status
      Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis
      Conditions: Retroperitoneal Fibrosis
    • NCT04314323
      Recruiting
      National Registry of IRPF in China
      Conditions: Idiopathic Retroperitoneal Fibrosis
    • NCT04312854
      Recruiting
      A Prospective Cohort Study of IRPF in China
      Conditions: Idiopathic Retroperitoneal Fibrosis
    • NCT03133949
      Unknown status
      Aortitis and Retroperitoneal Fibrosis: Evaluation of Diagnostic Criteria
      Conditions: Idiopathic Aortitis; Retroperitoneal Fibrosis
    • NCT01240850
      Unknown status
      Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial
      Conditions: Idiopathic Retroperitoneal Fibrosis; Perianeurysmal Retroperitoneal Fibrosis; Chronic Periaortitis
    • NCT01584388
      Completed
      Rituximab in IgG4-RD: A Phase 1-2 Trial
      Conditions: Retroperitoneal Fibrosis; Autoimmune Pancreatitis; Sialadenitis; Pseudotumor
    • NCT03009097
      Completed
      Atorvastatin as an Adjunct to DFDBA in Intrabony Defects
      Conditions: Chronic Periaortitis; Intrabony Periodontal Defect
    • NCT02705638
      Completed
      Treatment of IgG4-Related Disease With Revlimid and Rituximab
      Conditions: Immunoglobulin G Subclass 4 Related Disease; IgG4-related Disease; Autoimmune Pancreatitis; IgG4-related Sclerosing Cholangitis; Retroperitoneal Fibrosis
    • NCT02703194
      Completed
      Leflunomide for Maintenance of Remission in IgG4 Related Disease
      Conditions: Immunoglobulin G4 Related Sclerosing Disease
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations